5/31
02:03 pm
cdna
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/30
07:13 am
cdna
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress [Yahoo! Finance]
Low
Report
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress [Yahoo! Finance]
5/30
07:05 am
cdna
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
Low
Report
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
5/29
08:34 am
cdna
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant [Yahoo! Finance]
High
Report
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant [Yahoo! Finance]
5/29
08:05 am
cdna
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
High
Report
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
5/29
07:24 am
cdna
CareDx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
High
Report
CareDx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
5/29
07:05 am
cdna
CareDx to Participate in Upcoming Investor Conferences
High
Report
CareDx to Participate in Upcoming Investor Conferences
5/29
01:17 am
cdna
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
High
Report
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
5/22
12:01 am
cdna
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
5/17
08:17 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at Craig Hallum from $15.00 to $22.00. They now have a "buy" rating on the stock.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at Craig Hallum from $15.00 to $22.00. They now have a "buy" rating on the stock.
5/16
04:18 pm
cdna
Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies [Yahoo! Finance]
Medium
Report
Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies [Yahoo! Finance]
5/16
04:05 pm
cdna
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
Medium
Report
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
5/15
12:25 pm
cdna
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/13
03:18 pm
cdna
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
Low
Report
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
5/13
12:16 pm
cdna
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $14.00. They now have a "buy" rating on the stock.
5/13
10:26 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at Stephens from $15.00 to $18.00. They now have an "overweight" rating on the stock.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at Stephens from $15.00 to $18.00. They now have an "overweight" rating on the stock.
5/11
08:37 am
cdna
Earnings Update: Here's Why Analysts Just Lifted Their CareDx, Inc (NASDAQ:CDNA) Price Target To US$13.80 [Yahoo! Finance]
Low
Report
Earnings Update: Here's Why Analysts Just Lifted Their CareDx, Inc (NASDAQ:CDNA) Price Target To US$13.80 [Yahoo! Finance]
5/11
12:15 am
cdna
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
5/9
08:57 pm
cdna
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
High
Report
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
5/9
04:05 pm
cdna
CareDx Reports First Quarter 2024 Results
High
Report
CareDx Reports First Quarter 2024 Results
5/9
01:20 pm
cdna
CareDx, Inc (NASDAQ: CDNA) had its "buy" rating re-affirmed by analysts at Craig Hallum. They now have a $15.00 price target on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "buy" rating re-affirmed by analysts at Craig Hallum. They now have a $15.00 price target on the stock.
5/9
07:40 am
cdna
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine's Next Phase of Growth [Yahoo! Finance]
Medium
Report
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine's Next Phase of Growth [Yahoo! Finance]
5/7
11:13 am
cdna
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]
Low
Report
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]
5/3
04:21 pm
cdna
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
5/3
04:10 pm
cdna
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)